Skyepharma Plc (SKYEY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1998 | 12-1997 | 12-1996 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 51,300 | 14,380 | 33,510 |
| Receivables | 10,260 | 13,500 | 5,450 |
| Inventories | 1,960 | 450 | 420 |
| Other current assets | 20 | 10 | 10 |
| TOTAL | $63,540 | $28,340 | $39,390 |
| Non-Current Assets | |||
| Investments And Advances | 4,870 | 0 | 0 |
| Other Non-Current Assets | 2,670 | 3,770 | 750 |
| TOTAL | $7,540 | $3,770 | $750 |
| Total Assets | $114,230 | $70,390 | $54,000 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 15,870 | 13,730 | 9,810 |
| TOTAL | $15,870 | $13,730 | $9,810 |
| Non-Current Liabilities | |||
| Long Term Debt | 10,360 | 6,880 | 7,730 |
| Other Non-Current Liabilities | 77,640 | 126,270 | 106,390 |
| TOTAL | $88,000 | $133,150 | $114,120 |
| Total Liabilities | $103,880 | $146,880 | $123,930 |
| Shareholders' Equity | |||
| Common Shares | 70,850 | 60,370 | 54,480 |
| Retained earnings | -399,310 | -79,130 | 47,030 |
| Other shareholders' equity | 29,870 | -316,310 | -407,490 |
| TOTAL | $10,340 | $-76,490 | $-69,930 |
| Total Liabilities And Equity | $114,220 | $70,390 | $54,000 |